6.63
전일 마감가:
$7.07
열려 있는:
$7.1
하루 거래량:
195.08K
Relative Volume:
0.37
시가총액:
$237.76M
수익:
$59.63M
순이익/손실:
$-72.21M
주가수익비율:
-3.1571
EPS:
-2.1
순현금흐름:
$-30.85M
1주 성능:
+4.74%
1개월 성능:
+2.00%
6개월 성능:
+138.49%
1년 성능:
+52.06%
908 디바이시스 Stock (MASS) Company Profile
명칭
908 Devices Inc
전화
978-729-4478
주소
645 SUMMER STREET, BOSTON
MASS을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
MASS
908 Devices Inc
|
6.63 | 255.13M | 59.63M | -72.21M | -30.85M | -2.10 |
![]()
ABT
Abbott Laboratories
|
131.75 | 225.01B | 43.11B | 13.94B | 6.78B | 7.98 |
![]()
BSX
Boston Scientific Corp
|
103.17 | 154.32B | 18.49B | 2.50B | 3.49B | 1.68 |
![]()
SYK
Stryker Corp
|
381.91 | 144.71B | 23.82B | 2.92B | 4.02B | 7.55 |
![]()
MDT
Medtronic Plc
|
93.02 | 117.85B | 33.54B | 4.69B | 5.19B | 3.62 |
![]()
EW
Edwards Lifesciences Corp
|
78.26 | 45.90B | 5.69B | 1.41B | 577.90M | 6.95 |
908 디바이시스 Stock (MASS) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-08-05 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
2024-11-13 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
2023-02-07 | 개시 | Stephens | Overweight |
2021-10-15 | 재개 | Cowen | Outperform |
2021-01-12 | 개시 | Cowen | Outperform |
2021-01-12 | 개시 | SVB Leerink | Outperform |
2021-01-12 | 개시 | Stifel | Buy |
2021-01-12 | 개시 | William Blair | Outperform |
모두보기
908 디바이시스 주식(MASS)의 최신 뉴스
What momentum shifts mean for 908 Devices Inc.2025 Earnings Impact & Fast Gaining Stock Reports - Newser
STATE STREET CORP's Strategic Acquisition of 908 Devices Inc Shares - GuruFocus
What earnings revisions data tells us about 908 Devices Inc.Watch List & Free Verified High Yield Trade Plans - Newser
Order flow analysis tools used on 908 Devices Inc.Trade Ideas & Stepwise Trade Signal Implementation - Newser
Order Book Volume Tilts Bullish on 908 Devices Inc.2025 Top Gainers & Daily Entry Point Alerts - sundaytimes.kr
Detecting price anomalies in 908 Devices Inc. with AIPortfolio Gains Report & Risk Controlled Stock Pick Alerts - Newser
908 Devices Inc.’s volatility index tracking explainedJuly 2025 Summary & Stock Timing and Entry Methods - Newser
What recovery options are there for 908 Devices Inc.Quarterly Performance Summary & Risk Controlled Stock Pick Alerts - Newser
908 Devices’ (MASS) “Sell (D-)” Rating Reaffirmed at Weiss Ratings - Defense World
Watch for Trend Continuation in 908 Devices Inc. Next WeekTake Profit & Safe Capital Allocation Plans - beatles.ru
Chart overlay techniques for tracking 908 Devices Inc.July 2025 Outlook & Growth Focused Entry Reports - Newser
XTX Topco Ltd Trims Holdings in 908 Devices Inc. (NASDAQ:MASS) - Defense World
What’s next for 908 Devices Inc. stock pricePortfolio Risk Summary & Comprehensive Market Scan Reports - Newser
908 Devices Inc. shares rise 8.11% intraday after PolyPid reported positive Phase 3 SHIELD II Trial Results. - AInvest
908 Devices at Canaccord Genuity Conference: Strategic Shift to Defense Tech - Investing.com Canada
Is 908 Devices Inc. Starting a New UptrendPortfolio Risk Summary & AI Powered Market Entry Strategies - 선데이타임즈
How sentiment analysis helps forecast 908 Devices Inc.Sector Rotation and Stock Opportunity Analysis - Newser
Why 908 Devices Inc. stock attracts strong analyst attentionSwing Trade Signal and Price Prediction - Newser
Analyzing net buyer seller activity in 908 Devices Inc.Fast Movement Forecast for Trading Success - Newser
Leerink Partnrs Forecasts Stronger Earnings for 908 Devices - Defense World
Is 908 Devices Inc. still worth holding after the dipProven Trading System with Consistent Gains - Newser
908 Devices Inc. (NASDAQ:MASS) Just Reported And Analysts Have Been Lifting Their Price Targets - 富途牛牛
908 Devices Inc. (NASDAQ:MASS) Analysts Remain Bullish Despite Q2 Earnings Miss - AInvest
908 Devices Inc. (NASDAQ:MASS) Analysts Are Pretty Bullish On The Stock After Recent Results - Yahoo Finance
908 Devices Inc. Reports Strong Growth and Optimism - TipRanks
Leerink Partners Maintains 908 Devices(MASS.US) With Buy Rating, Maintains Target Price $12 - 富途牛牛
908 Devices Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
908 Devices Raises Revenue Outlook and Reports 14% YoY Growth in Q2 2025 - AInvest
Repligen Corporation shares fall 2.74% intraday after 908 Devices Inc. acquired assets of KAF Manufacturing. - AInvest
908 Devices Inc. shares rise 3.47% intraday after acquiring assets of KAF Manufacturing. - AInvest
908 Devices Inc. (NASDAQ:MASS) Q2 2025 Earnings Call Transcript - Insider Monkey
908 Devices (MASS) Receives a Buy from William Blair - The Globe and Mail
908 Devices Inc. (MASS) Reports Q2 Loss, Tops Revenue Estimates - MSN
908 Devices 2025 Q2 Earnings Net Loss Widens 6% Despite Revenue Growth - AInvest
908 Devices Q2 2025 Earnings: Revenue Surpasses Estimates at $13M, EPS Misses at -$0.21 - AInvest
908 Devices Upgraded to Outperform by Leerink with $12 Price Target - AInvest
908 Devices Inc (MASS) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Rising ... By GuruFocus - Investing.com Canada
908 Devices Inc. Reports Q2 Growth and Raises Outlook - TipRanks
908 Devices Inc (MASS) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Rising Expenses - GuruFocus
908 Devices (MASS) Q2 Revenue Jumps 14% - The Globe and Mail
908 Devices (MASS) Q2 Revenue Jumps 14% - The Motley Fool
FRONTERA ENERGY CORPORATION ANNOUNCE DIVESTMENT OF NON-CORE ASSETS IN ECUADOR - The Globe and Mail
908 Devices Inc. acquired Assets of KAF Manufacturing Company, Inc for $2.8 million. - MarketScreener
908 Devices stock rating upgraded by Leerink Partners on forensics focus - Investing.com Canada
Contradictions Unveiled: 908 Devices' 2025Q2 Earnings Call Raises Questions on Revenue Growth and Market Opportunities - AInvest
908 Devices Q2 2025 Earnings Conference Call Highlights - AInvest
Transcript : 908 Devices Inc., Q2 2025 Earnings Call, Aug 05, 2025 - MarketScreener
Earnings call transcript: 908 Devices Q2 2025 revenue rises, stock slides - Investing.com
908 Devices Inc reports results for the quarter ended June 30Earnings Summary - TradingView
908 Devices Surpasses Revenue Estimates, Posts Q2 Loss of $0.18 per Share - AInvest
908 Devices Inc. SEC 10-Q Report - TradingView
908 디바이시스 (MASS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):